Socrus Pharmaceuticals Limited, a active public limited company, was established on 13 February 1986 in Dhar, Madhya Pradesh, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24232MP1986PLC003300. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹10.00 Cr and a paid-up capital of ₹8.18 Cr.
It upholds a active non-compliant status. Its leadership includes Rajshree Trivedi (Director), Madhvi Agnihotri (Director), Rajeev Agnihotri (Managing Director). Past directors included Rita Punjawani, Yukta Panjwani. It holds ₹17.33 Cr open charges and ₹7.65 M settled loans. Its latest AGM occurred on 29 September 2012, with the balance sheet filed on 31 March 2012. It is based at Plot No-252 Sector-I, Pithampur, Dhar, Madhya Pradesh, 454775.
U24232MP1986PLC003300
003300
13 February 1986
₹10.00 Cr
₹8.18 Cr
Roc Gwalior
Unlisted
Active
Explore comprehensive insights into Socrus Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rajshree Trivedi | Director | 05 Jun 1990 | Current |
| Madhvi Agnihotri | Director | 10 Jun 1995 | Current |
| Rajeev Agnihotri | Managing Director | 27 Jan 1996 | Current |
| Sanjay Kumar Upadhyay | Additional Director | 30 Jan 2012 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 17 Jul 2012 | Past |
| Pramod Abcsdd | Additional Director | 17 Jul 2012 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Socrus Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Socrus Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹173,293,000.00
₹7,648,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Aug 2006 | Panjab National Bank | ₹5.75 Cr | Open |
| 27 Dec 2004 | Asset Reconstruction Company (India) Limited | ₹1.50 M | Open |
| 22 Nov 2004 | Asset Reconstruction Company (India) Limited | ₹10.25 Cr | Open |
| 13 Aug 2004 | Centurion Bank Ltd. | ₹0.11 M | Open |
| 26 Jun 2004 | Asset Reconstruction Company (India) Limited | ₹0.39 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Socrus Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Socrus Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Socrus Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Asset Reconstruction Company (India) Limited of Rs. 0.15 Cr registered on 27 Dec 2004 with Charge ID 90209799 was modified on 16 Oct 2014. was documented.
Progress on A charge with Asset Reconstruction Company (India) Limited of Rs. 10.25 Cr registered on 22 Nov 2004 with Charge ID 90206231 was modified on 16 Oct 2014. was documented.
The activity A charge with Asset Reconstruction Company (India) Limited of Rs. 0.04 Cr registered on 26 Jun 2004 with Charge ID 90209614 was modified on 16 Oct 2014. was completed.
The activity A charge with Asset Reconstruction Company (India) Limited of Rs. 0.08 Cr registered on 18 Aug 1998 with Charge ID 90210166 was modified on 16 Oct 2014. was completed.
A charge with Asset Reconstruction Company (India) Limited of Rs. 0.10 Cr registered on 18 Aug 1998 with Charge ID 90205379 was modified on 16 Oct 2014. was recorded as a recent event.
Progress on A charge with Asset Reconstruction Company (India) Limited of Rs. 0.35 Cr registered on 27 Dec 1994 with Charge ID 90204990 was modified on 16 Oct 2014. was documented.
The CIN of Socrus Pharmaceuticals Limited is U24232MP1986PLC003300.
Socrus Pharmaceuticals Limited is headquartered at Plot No-252 Sector-I, Pithampur, Dhar, Madhya Pradesh, 454775.
Socrus Pharmaceuticals Limited was incorporated on 13 February 1986.
The current directors of Socrus Pharmaceuticals Limited are
The primary industry of Socrus Pharmaceuticals Limited is Pharma.
Socrus Pharmaceuticals Limited is unlisted.
The authorized capital of Socrus Pharmaceuticals Limited is ₹10.00 Cr, and the paid-up capital is ₹8.18 Cr.
The compliance status of Socrus Pharmaceuticals Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX